Literature DB >> 9590599

Surveillance of cryptococcosis in Alabama, 1992-1994.

C J Thomas1, J Y Lee, L A Conn, M E Bradley, R W Gillespie, S R Dill, R W Pinner, P G Pappas.   

Abstract

PURPOSE: Although cryptococcosis is a significant opportunistic infection among patients with human immunodeficiency virus (HIV), there is conflicting information on rates of cryptococcosis among HIV-positive and HIV-negative patients. Precise state-wide epidemiologic data for cryptococcosis are not available in Alabama.
METHODS: We conducted an active laboratory and hospital medical record-based surveillance for cryptococcosis in Alabama from October 1, 1992 to September 30, 1994. A case of cryptococcosis was defined as a patient's initial episode of cryptococcal disease and based on either a positive culture for C. neoformans from any normally sterile site, a positive latex agglutination serologic test for cryptococcal antigen in CSF or serum, or histopathologic findings consistent with C. neoformans.
RESULTS: Over the two year period, 153 cases were identified. The diagnosis was based on positive culture (37%), positive antigen (24%), positive autopsy culture (2%), and histopathologic findings (4%). Further, 33% of the total cases were diagnosed from combined positive culture, antigen, or histopathology. Of the total 153 cases, 55% were in HIV-positive patients and 44% were in HIV-negative individuals and one case (1%) had an unknown HIV status. The overall annual incidence rate of cryptococcosis was 1.89 cases per 100,000 population. The incidence was 1638.7 per 100,000 in the HIV-positive population and 0.84 per 100,000 in the HIV-negative population.
CONCLUSION: The first Alabama statewide active surveillance system for cryptococcosis confirms previous observations that rates of cryptococcosis are consistently higher in HIV-infected individuals than in their HIV-negative counterparts. In Alabama, cryptococcosis occurs more commonly in urban residents and in men. Cryptococcosis in HIV-positive persons is more likely to occur in the 20 to 44 year age group, whereas cryptococcosis in HIV-negative persons is more likely to occur in those greater than 45 years old.

Entities:  

Mesh:

Year:  1998        PMID: 9590599     DOI: 10.1016/s1047-2797(97)00234-2

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  7 in total

1.  Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis.

Authors:  Eleftherios Mylonakis; Frederick M Ausubel; John R Perfect; Joseph Heitman; Stephen B Calderwood
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-15       Impact factor: 11.205

2.  Endogenous excess cortisol production and diabetes mellitus as predisposing factors for pulmonary cryptococcosis: a case report and literature review.

Authors:  B Thangakunam; D J Christopher; S Kurian; R Thomas; P James
Journal:  Lung India       Date:  2008-10

3.  Challenge of Drosophila melanogaster with Cryptococcus neoformans and role of the innate immune response.

Authors:  Yiorgos Apidianakis; Laurence G Rahme; Joseph Heitman; Frederick M Ausubel; Stephen B Calderwood; Eleftherios Mylonakis
Journal:  Eukaryot Cell       Date:  2004-04

4.  Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007.

Authors:  Eleni Galanis; Laura Macdougall; Sarah Kidd; Mohammad Morshed
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

5.  A Case of Pulmonary Cryptococcosis in an Immunocompetent Male Patient Diagnosed by a Percutaneous Supraclavicular Lymph Node Biopsy.

Authors:  Ji Hee Sung; Do Hoon Kim; Mi-Jung Oh; Kyoung Ju Lee; Young A Bae; Kye Won Kwon; Seung Min Lee; Ho Joon Kang; Jinyoung Choi
Journal:  Tuberc Respir Dis (Seoul)       Date:  2015-06-30

6.  The temperature-sensitive role of Cryptococcus neoformans ROM2 in cell morphogenesis.

Authors:  Beth Burgwyn Fuchs; Robin J Tang; Eleftherios Mylonakis
Journal:  PLoS One       Date:  2007-04-11       Impact factor: 3.240

7.  Prevalence of cryptococcal meningitis among people living with human immunodeficiency virus/acquired immunodeficiency syndrome in a Tertiary Care Hospital, Southern Odisha, India.

Authors:  Muktikesh Dash; Sanghamitra Padhi; Rani Sahu; Jyotirmayee Turuk; Swetalona Pattanaik; Pooja Misra
Journal:  J Nat Sci Biol Med       Date:  2014-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.